Publications by authors named "Kevin Dack"

Claim this Profile
D
Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases.
Mark D Andrews, Kevin N Dack, Marcel J de Groot, Maja Lambert, Carl J Sennbro

J Med Chem· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment.
Stefan Eirefelt, Martin Stahlhut, Naila Svitacheva, Martin A Carnerup, Joel Mauricio Correa Da Rosa, Kevin Neil Dack

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction.
Sanja Koštrun, Andrea Fajdetić, Dijana Pešić, Karmen Brajša, Vlatka Bencetić Mihaljević, Kevin Dack

J Med Chem· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical 'dual-soft' glucocorticoid receptor agonist for dermatology.
Kevin N Dack, Patrick S Johnson, Krister Henriksson, Stefan Eirefelt, Martin A Carnerup

Bioorg Med Chem Lett· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-Based Discovery of 6-Arylindazole JAK Inhibitors.
Andreas Ritzén, Morten D Sørensen, Kevin N Dack, Daniel R Greve, Anders Jerre

ACS Med Chem Lett· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib.
Qinhua Huang, Ted W Johnson, Simon Bailey, Alexei Brooun, Kevin D Bunker, Kevin N Dack

J Med Chem· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of libraries to access new chemical space: applications to CRTH2.
M Abid Masood, Mark Gardner, Kevin Dack, David Winpenny, Graham Lunn

Bioorg Med Chem Lett· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic combinatorial mass spectrometry leads to inhibitors of a 2-oxoglutarate-dependent nucleic acid demethylase.
Esther C Y Woon, Marina Demetriades, Eleanor A L Bagg, WeiShen Aik, Svetlana M Krylova, Kevin N Dack

J Med Chem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acidic triazoles as soluble guanylate cyclase stimulators.
Lee R Roberts, Paul A Bradley, Mark E Bunnage, Katherine S England, David Fairman, Kevin N Dack

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonists.
Chuangxing Guo, Angelica Linton, Susan Kephart, Martha Ornelas, Mason Pairish, Kevin Dack

J Med Chem· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stability.
Patrick S Johnson, Thomas Ryckmans, Justin Bryans, Dave M Beal, Kevin N Dack

Bioorg Med Chem Lett· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitors.
Melanie S Glossop, Richard J Bazin, Kevin N Dack, David N A Fox, Graeme A MacDonald

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of a pyrazole series of progesterone antagonists; Part 1.
Kevin N Dack, Sarah Skerratt, Patrick S Johnson, Paul A Bradley, Ian R Marsh

Bioorg Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel series of highly selective inhibitors of MMP-3.
Gavin A Whitlock, Kevin N Dack, Roger P Dickinson, Mark L Lewis

Bioorg Med Chem Lett· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist.
Kevin Beaumont, Robert Webster, Iain Gardner, Kevin Dack

Curr Drug Metab· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design and synthesis of a novel series of indole derived selective ET(A) antagonists.
David J Rawson, Kevin N Dack, Roger P Dickinson, Kim James

Bioorg Med Chem Lett· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis